Because the origin of ulcers is directly related to the reduction of the mucus barrier,
we propose that the gastroprotective action promoted
by b-myrcene could be related to its ability to increase the amount of gastric mucus.
Treatment with b-myrcene caused an increase in the amount
of adhered gastric mucus compared to the vehicle-treated group.